Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Risk factors and outcomes of biliary complications after adult living-donor liver transplant

Official title: Risk Factors and Outcome of Biliary Complications Following Adult Living Donor Liver Transplantation in Al-Rajhy Liver Hospital in Upper Egypt.

Run by Assiut University · NCT03789383 · Data updated 2026-11-12

This project will look at how often and why bile-duct problems happen and what the outcomes are in adults who had a living-donor liver transplant at Al-Rajhy/Assiut University.

More Liver Transplant trials

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorAssiut University
Academic / other
Locations2 sites (Asyut and 1 other locations)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedJanuary 1, 2027
Study endsJuly 1, 2027
Registry record updatedJuly 24, 2025
Trial IDNCT03789383 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged over 18 who received a living-donor liver transplant at Al‑Rajhy Liver Hospital (Assiut University) are the intended participants.

Probably not a fit

Pediatric patients and recipients of cadaveric (deceased-donor) liver transplants are excluded and will not be included or directly benefit from this study's results.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational project combining a retrospective chart review with prospective data collection from adult living-donor liver transplant recipients at Al‑Rajhy Liver Hospital, Assiut University. The team will document the frequency and specific types of biliary complications (anastomotic and non-anastomotic strictures, leaks, bilomas, stones, cholangitis, etc.) and collect perioperative and clinical variables. Analyses will seek associations between patient, donor, and surgical factors and the occurrence and clinical course of biliary complications. The study excludes pediatric and cadaveric (deceased-donor) transplants and does not introduce experimental treatments.

Why it matters

Potential benefit: If successful, the findings could help clinicians identify modifiable risk factors and improve prevention and management of biliary complications after living-donor liver transplant.

How similar studies have gone: Previous clinical series have shown that biliary complications are common after living-donor liver transplantation and that identifying perioperative risk factors can reduce complication rates, so this work builds on established but variable evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults more than 18 y with living donor liver transplantation in Al-Rajhy liver hospital , Assiut university,Egypt

Exclusion Criteria:

* pediatric liver transplantation
* cadaveric liver transplantation

Where it's running

  • Alrajhy center for hepatobiliary disorders
    Asyut, Egypt
    Recruiting
  • Al-Rajhy liver hospital
    Asyut, Egypt
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.